STXB4_HUMAN - dbPTM
STXB4_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID STXB4_HUMAN
UniProt AC Q6ZWJ1
Protein Name Syntaxin-binding protein 4
Gene Name STXBP4
Organism Homo sapiens (Human).
Sequence Length 553
Subcellular Localization Cytoplasm.
Protein Description Plays a role in the translocation of transport vesicles from the cytoplasm to the plasma membrane. Inhibits the translocation of SLC2A4 from intracellular vesicles to the plasma membrane by STX4A binding and preventing the interaction between STX4A and VAMP2. Stimulation with insulin disrupts the interaction with STX4A, leading to increased levels of SLC2A4 at the plasma membrane. May also play a role in the regulation of insulin release by pancreatic beta cells after stimulation by glucose (By similarity)..
Protein Sequence MNKNTSTVVSPSLLEKDPAFQMITIAKETGLGLKVLGGINRNEGPLVYIQEIIPGGDCYKDGRLKPGDQLVSVNKESMIGVSFEEAKSIITGAKLRLESAWEIAFIRQKSDNIQPENLSCTSLIEASGEYGPQASTLSLFSSPPEILIPKTSSTPKTNNDILSSCEIKTGYNKTVQIPITSENSTVGLSNTDVASAWTENYGLQEKISLNPSVRFKAEKLEMALNYLGIQPTKEQHQALRQQVQADSKGTVSFGDFVQVARNLFCLQLDEVNVGAHEISNILDSQLLPCDSSEADEMERLKCERDDALKEVNTLKEKLLESDKQRKQLTEELQNVKQEAKAVVEETRALRSRIHLAEAAQRQAHGMEMDYEEVIRLLEAKITELKAQLADYSDQNKESVQDLKKRIMVLDCQLRKSEMARKTFEASTEKLLHFVEAIQEVFSDNSTPLSNLSERRAVLASQTSLTPLGRNGRSIPATLALESKELVKSVRALLDMDCLPYGWEEAYTADGIKYFINHVTQTTSWIHPVMSVLNLSRSEENEEDCSRELPNQKS
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
5Phosphorylation---MNKNTSTVVSPS
---CCCCCCCCCCHH
27.6421712546
6Phosphorylation--MNKNTSTVVSPSL
--CCCCCCCCCCHHH
28.7025159151
7Phosphorylation-MNKNTSTVVSPSLL
-CCCCCCCCCCHHHH
23.9225159151
10PhosphorylationKNTSTVVSPSLLEKD
CCCCCCCCHHHHCCC
12.3925159151
12PhosphorylationTSTVVSPSLLEKDPA
CCCCCCHHHHCCCCC
37.7721712546
16UbiquitinationVSPSLLEKDPAFQMI
CCHHHHCCCCCCCEE
69.8221906983
16 (in isoform 1)Ubiquitination-69.8221906983
27UbiquitinationFQMITIAKETGLGLK
CCEEEEHHHHCCCEE
52.5421906983
27 (in isoform 1)Ubiquitination-52.5421906983
60UbiquitinationIPGGDCYKDGRLKPG
ECCCCCCCCCCCCCC
61.10-
65UbiquitinationCYKDGRLKPGDQLVS
CCCCCCCCCCCEEEE
45.66-
82PhosphorylationKESMIGVSFEEAKSI
CHHHCCCCHHHHHHH
23.0225159151
99PhosphorylationGAKLRLESAWEIAFI
CCEEEHHHHHHHEEE
43.18-
151PhosphorylationPEILIPKTSSTPKTN
CCEEECCCCCCCCCC
23.6621712546
156UbiquitinationPKTSSTPKTNNDILS
CCCCCCCCCCCCHHH
65.06-
157PhosphorylationKTSSTPKTNNDILSS
CCCCCCCCCCCHHHC
40.22-
163PhosphorylationKTNNDILSSCEIKTG
CCCCCHHHCCEEECC
33.0225159151
164PhosphorylationTNNDILSSCEIKTGY
CCCCHHHCCEEECCC
16.6021815630
168UbiquitinationILSSCEIKTGYNKTV
HHHCCEEECCCCCEE
17.38-
208PhosphorylationYGLQEKISLNPSVRF
CCCCCCCCCCHHHCH
32.9128555341
212PhosphorylationEKISLNPSVRFKAEK
CCCCCCHHHCHHHHH
25.5028857561
233UbiquitinationYLGIQPTKEQHQALR
HCCCCCCHHHHHHHH
63.16-
248UbiquitinationQQVQADSKGTVSFGD
HHHHHCCCCCCCHHH
60.18-
250PhosphorylationVQADSKGTVSFGDFV
HHHCCCCCCCHHHHH
19.4029214152
252PhosphorylationADSKGTVSFGDFVQV
HCCCCCCCHHHHHHH
24.2922199227
323UbiquitinationEKLLESDKQRKQLTE
HHHHHCHHHHHHHHH
62.37-
326UbiquitinationLESDKQRKQLTEELQ
HHCHHHHHHHHHHHH
47.36-
346PhosphorylationAKAVVEETRALRSRI
HHHHHHHHHHHHHHH
14.0329978859
380UbiquitinationVIRLLEAKITELKAQ
HHHHHHHHHHHHHHH
40.56-
382PhosphorylationRLLEAKITELKAQLA
HHHHHHHHHHHHHHC
34.2623403867
385 (in isoform 1)Ubiquitination-28.0521906983
385UbiquitinationEAKITELKAQLADYS
HHHHHHHHHHHCCCC
28.0521906983
391PhosphorylationLKAQLADYSDQNKES
HHHHHCCCCCCCHHH
14.4529496907
392PhosphorylationKAQLADYSDQNKESV
HHHHCCCCCCCHHHH
33.0129496907
396UbiquitinationADYSDQNKESVQDLK
CCCCCCCHHHHHHHH
45.812190698
396 (in isoform 1)Ubiquitination-45.8121906983
421UbiquitinationRKSEMARKTFEASTE
CHHHHHHHHHHHHHH
48.29-
445PhosphorylationQEVFSDNSTPLSNLS
HHHHCCCCCCCCCHH
36.07-
446PhosphorylationEVFSDNSTPLSNLSE
HHHCCCCCCCCCHHH
34.21-
460PhosphorylationERRAVLASQTSLTPL
HHHHHHHCCCCCCCC
29.8117525332
462PhosphorylationRAVLASQTSLTPLGR
HHHHHCCCCCCCCCC
24.1721082442
463PhosphorylationAVLASQTSLTPLGRN
HHHHCCCCCCCCCCC
23.7017525332
465PhosphorylationLASQTSLTPLGRNGR
HHCCCCCCCCCCCCC
19.0828122231
483UbiquitinationATLALESKELVKSVR
CCHHHCCHHHHHHHH
45.77-
487UbiquitinationLESKELVKSVRALLD
HCCHHHHHHHHHHHC
56.72-
519PhosphorylationKYFINHVTQTTSWIH
HHHHHHHHCCCCCHH
16.7927251275
521PhosphorylationFINHVTQTTSWIHPV
HHHHHHCCCCCHHHH
17.2727251275
522PhosphorylationINHVTQTTSWIHPVM
HHHHHCCCCCHHHHH
16.5527251275
523PhosphorylationNHVTQTTSWIHPVMS
HHHHCCCCCHHHHHH
27.6727251275
545PhosphorylationEENEEDCSRELPNQK
CCCHHHHHHCCCCCC
40.9028985074

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources

Oops, there are no upstream regulatory protein records of STXB4_HUMAN !!

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference
99SPhosphorylation

-
99SPhosphorylation

-

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of STXB4_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions

Oops, there are no PPI records of STXB4_HUMAN !!

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of STXB4_HUMAN

loading...

Related Literatures of Post-Translational Modification
Phosphorylation
ReferencePubMed
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach.";
Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.;
Anal. Chem. 81:4493-4501(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-6 AND SER-10, AND MASSSPECTROMETRY.
"A quantitative atlas of mitotic phosphorylation.";
Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.;
Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-10, AND MASSSPECTROMETRY.
"Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle.";
Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.;
Mol. Cell 31:438-448(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-6; SER-10 AND THR-465,AND MASS SPECTROMETRY.
"ATM and ATR substrate analysis reveals extensive protein networksresponsive to DNA damage.";
Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III,Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N.,Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J.;
Science 316:1160-1166(2007).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-460 AND SER-463, ANDMASS SPECTROMETRY.

TOP